NEW YORK – Harvard's Wyss Institute for Biologically Inspired Engineering announced Monday its nasopharyngeal swab and toehold switch technologies have been licensed by Agile Biodetection to develop diagnostic solutions for SARS-CoV-2.
NEW YORK – Harvard's Wyss Institute for Biologically Inspired Engineering announced Monday its nasopharyngeal swab and toehold switch technologies have been licensed by Agile Biodetection to develop diagnostic solutions for SARS-CoV-2.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.